HIPAA-compliant · Same-day admissions available
Robin Campbell, LMFT, PHD Xylazine and fentanyl are raising new concerns in the illicit drug supply and the opioid epidemic.
Maverick
Clinical Editorial Team
Xylazine and fentanyl are raising new concerns in the illicit drug supply and the opioid epidemic. Xylazine is a veterinary tranquilizer, muscle relaxant, and central nervous system depressant that may be mixed with synthetic opioids, illicit opioids, and other drugs. Xylazine is not approved for human use by the Food and Drug Administration (FDA) and is primarily used as a sedative and muscle relaxant in veterinary medicine. Families in Knoxville should understand how tranq dope can affect normal breathing, blood flow, opioid overdose risk, skin ulcers, severe wounds, and soft tissue infections.
Xylazine is a non-opioid sedative used in veterinary medicine, mainly for large animals. It is not approved for human use by the Food and Drug Administration (FDA), but it has entered the illegal drug supply in many areas. Dealers may mix xylazine with fentanyl because it can extend the sedating effects of opioids.
Xylazine can cause hypotension (low blood pressure), central nervous system depression, respiratory depression, bradycardia (slow heart rate), and is associated with serious skin ulcers. Because it is not an opioid, naloxone reverses the effects of fentanyl but does not reverse those of xylazine, making overdose management complex. This makes xylazine and fentanyl especially dangerous for people who use street opioids.
Xylazine has spread across the illegal drug supply in many regions, with its increasing presence in the illicit opioid supply linked to an increased risk of skin ulceration and fatal overdose. It is often mixed with fentanyl to change how long the effects last. Xylazine is frequently added to illicitly manufactured fentanyl to prolong the high and increase dealer profits. People who use drugs may not know xylazine is present, which increases risk. This shift matters because overdoses can become harder to recognize and treat. Xylazine can deepen sedation and slow the body beyond typical opioid effects. This creates new risks for both individuals and families trying to respond.
Xylazine is called tranq because it acts as a strong sedative. It can cause heavy drowsiness, slowed movement, and a lack of response. People may appear almost unconscious even at lower doses. Users report that combining xylazine with fentanyl or heroin produces euphoric effects and induces a state of profound, long-lasting sedation often described as ‘the nod.’
The term “tranq” also reflects how the drug affects the body over time. Sedation may last longer than fentanyl alone, which can delay recovery after use. This increases the danger of repeated dosing and overdose.
The use of xylazine and fentanyl in combination is increasingly prevalent, with xylazine use now commonly found in street opioids to prolong effects or mimic heroin. Fentanyl produces a fast, intense high, while xylazine, often referred to as ‘tranq,’ extends sedation, making the drug feel stronger or last longer.
This combination increases the risk of fatal overdose, as the body must process both substances at once, raising the likelihood of severe respiratory depression and overdose complications. It also makes withdrawal and treatment more complex.
People are exposed to xylazine through contaminated street drugs. People who inject drugs are at particular risk of exposure to xylazine when using contaminated street opioids, as xylazine is commonly added to fentanyl, heroin, or counterfeit pills without clear labeling. This means a person may use it without knowing. Exposure can happen even with small amounts. Each use carries risk because the strength and mix can change. This uncertainty increases the chance of overdose and serious health effects.
Fentanyl binds to opioid receptors in the brain and slows breathing. Xylazine acts on the central nervous system as a sedative, reducing nerve signals and further depressing respiratory and cardiovascular functions. Together, they suppress key body functions.
This combination can lead to deep sedation, low heart rate, and low blood pressure. The brain may not respond to oxygen needs, which increases the risk of loss of consciousness or death. Repeated exposure can also damage physical health over time. Disease control efforts are crucial in managing and preventing the health consequences associated with xylazine and fentanyl exposure.
The risk of overdose is high because both substances slow breathing and body function. Xylazine is not reversed by naloxone, which makes overdose response more difficult. Quick action, including naloxone use and emergency care, is critical to improve survival. If xylazine and fentanyl overdose is suspected, seeking prompt medical attention is essential to prevent serious complications and improve outcomes.
Naloxone can reverse the opioid effects of fentanyl during an overdose. It does not reverse xylazine, but it can restore breathing when opioids are involved. This makes naloxone a critical first step even when xylazine is suspected.
Families should still give naloxone and call 911 right away. Multiple doses may be needed because fentanyl is strong and fast-acting. Emergency care is needed to manage sedation, breathing, and heart function linked to xylazine.
Xylazine has become more common in the illegal drug supply. It is often found mixed with fentanyl and other opioids. Reports show increasing detection in overdose cases across the United States. This rise increases risk for people who use street drugs. The mix of xylazine and fentanyl creates unpredictable effects. This makes prevention and awareness more important. The drug enforcement administration has issued a public safety alert on the presence of xylazine in drug seizures, while post mortem toxicology tests, J Addict Med, and national institute research show its sedative effects, reduced heart rate risks, and under-reported public health impact on drug abuse.
Local drug supplies can change quickly and may include xylazine. Families may not realize how common fentanyl contamination has become. This increases the risk of accidental overdose.
Awareness helps families act faster in an emergency. Knowing the signs and having naloxone on hand can save lives. Early action can make a critical difference.
Short-Term:
Long-Term:
Xylazine has been linked to serious skin wounds. These wounds can appear even without injection at the site. They may become infected and require medical care.
Other risks include low blood pressure, slow heart rate, and reduced oxygen levels. These effects can damage the body over time. Early treatment can help reduce complications.
Withdrawal from fentanyl can cause strong physical symptoms. These may include nausea, sweating, pain, and cravings. Xylazine withdrawal may also include anxiety, agitation, and sleep problems. Medical support is often needed to manage withdrawal safely. Symptoms can overlap and become hard to treat without care. Supervision can help reduce risk and improve comfort. Healthcare providers play a crucial role in managing xylazine withdrawal, addressing wound care, and offering harm reduction education to individuals at risk.
Xylazine and fentanyl use often overlap with mental health issues. Common conditions include depression, anxiety, trauma, and post-traumatic stress disorder. These issues can increase substance use and relapse risk.
Substances like alcohol, benzodiazepines, meth, and cocaine may also be involved. Mixing substances raises overdose risk and worsens mental health symptoms. Treatment should address both substance use and mental health together.
Medication assisted treatment can help reduce cravings and withdrawal symptoms. Medications like buprenorphine or methadone support opioid recovery. These medications work best when combined with therapy.
MAT can improve stability and lower overdose risk. It helps people stay engaged in care. This approach supports long-term recovery from fentanyl use.
Family support can help people stay engaged in treatment. Encouragement and accountability can improve outcomes. Clear communication helps rebuild trust over time.
Families can also learn about addiction and recovery. This reduces stigma and improves support at home. Involvement can make recovery more stable.
Treatment should be considered when use becomes frequent or risky. Signs include overdose, withdrawal, or health problems. Mental health changes are also a key warning sign. Early treatment can prevent more serious harm. Waiting may increase medical and emotional risks. Seeking help early can improve outcomes.
These options can be combined based on need. A clinical assessment helps guide the best plan.
Many insurance plans cover addiction treatment services. Coverage may include detox, residential care, outpatient programs, therapy, and medication assisted treatment. Benefits vary based on the provider and plan. It is important to verify coverage early. This helps avoid delays in care. Treatment centers can often assist with insurance checks and next steps.
Xylazine combined with fentanyl can increase overdose deaths, fatal overdose risk, and other negative consequences tied to drug use. Harm reduction strategies like naloxone, rescue breaths, fentanyl test strips, xylazine test strips, sterile syringes, and wound care can help reduce risk. Treatment can help people address substance use disorders, drug alcohol concerns, injection drug use, and long-term recovery needs.
At New Hope Healthcare, as an in-network provider we work with most insurance plans, such as:
If you or a loved one are struggling with mental health challenges or substance abuse, seeking treatment and emotional support is crucial. Consulting a doctor can provide the necessary support and guidance for your teen. Reach out to New Hope Healthcare today. Our team of compassionate professionals is here to support your journey towards lasting well-being. Effective medication management is a crucial part of the treatment process to ensure safety and success. Give us a call at 866-799-0806.
Visit SAMHSA for more information.
Xylazine is a sedative often found in fentanyl, which increases overdose and wound risks.
Naloxone reverses fentanyl effects, not xylazine, but families should still use it and call 911.
Treatment may include assessment, medical support, therapy, MAT, and mental health care.
It is called tranq because it causes heavy sedation and slowed movement.
Signs may include extreme sleepiness, slow breathing, confusion, wounds, and withdrawal.
Xylazine is increasingly found in illegal fentanyl, though local supply can change.
](https://www.cdc.gov/overdose-prevention/about/what-you-should-know-about-xylazine.html)
](https://www.dea.gov/xylazine-information)
](https://www.fda.gov/news-events/press-announcements/fda-takes-action-restrict-unlawful-import-xylazine)
](https://nida.nih.gov/research-topics/xylazine)
In This Article
Tags
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Many parents are concerned about youth vaping, especially as vaping devices, e cigarettes, marijuana products, and other tobacco products become more common among high school students and other young people.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Alcohol use disorder affects people from all backgrounds and can range from risky drinking patterns to severe alcohol use disorder.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Teen vaping has become a growing concern for families across Knox County. Many parents worry about nicotine addiction, THC use, e cigarettes, and the long-term effects of tobacco and nicotine exposure on adolescents and young adults.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Opioid addiction can affect health, work, family, and daily life. Many patients who start with prescription pain relievers may develop substance use disorders that are hard to stop without support.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD A benzo taper can be an important part of recovery for people who have become dependent on Xanax, Klonopin, Ativan, or other benzodiazepines.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Xylazine, a veterinary tranquilizer, is increasingly being found alongside fentanyl and other drugs in the illicit drug market, creating new challenges during the ongoing overdose crisis.
New Hope Health offers client-centered services. Reach out for a confidential consultation and see exactly how we'd apply these strategies to your facility.
